JP7198021B2 - コハク酸ソリフェナシン含有製剤 - Google Patents

コハク酸ソリフェナシン含有製剤 Download PDF

Info

Publication number
JP7198021B2
JP7198021B2 JP2018177471A JP2018177471A JP7198021B2 JP 7198021 B2 JP7198021 B2 JP 7198021B2 JP 2018177471 A JP2018177471 A JP 2018177471A JP 2018177471 A JP2018177471 A JP 2018177471A JP 7198021 B2 JP7198021 B2 JP 7198021B2
Authority
JP
Japan
Prior art keywords
solifenacin succinate
added
solifenacin
succinate
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018177471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020045323A5 (enExample
JP2020045323A (ja
Inventor
卓也 松川
康史 福原
友則 奥村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sawai Pharmaceutical Co Ltd
Original Assignee
Sawai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sawai Pharmaceutical Co Ltd filed Critical Sawai Pharmaceutical Co Ltd
Priority to JP2018177471A priority Critical patent/JP7198021B2/ja
Publication of JP2020045323A publication Critical patent/JP2020045323A/ja
Publication of JP2020045323A5 publication Critical patent/JP2020045323A5/ja
Application granted granted Critical
Publication of JP7198021B2 publication Critical patent/JP7198021B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018177471A 2018-09-21 2018-09-21 コハク酸ソリフェナシン含有製剤 Active JP7198021B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018177471A JP7198021B2 (ja) 2018-09-21 2018-09-21 コハク酸ソリフェナシン含有製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018177471A JP7198021B2 (ja) 2018-09-21 2018-09-21 コハク酸ソリフェナシン含有製剤

Publications (3)

Publication Number Publication Date
JP2020045323A JP2020045323A (ja) 2020-03-26
JP2020045323A5 JP2020045323A5 (enExample) 2021-08-26
JP7198021B2 true JP7198021B2 (ja) 2022-12-28

Family

ID=69900714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018177471A Active JP7198021B2 (ja) 2018-09-21 2018-09-21 コハク酸ソリフェナシン含有製剤

Country Status (1)

Country Link
JP (1) JP7198021B2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113440492B (zh) * 2020-03-27 2024-10-15 广东东阳光药业股份有限公司 一种毒蕈碱受体拮抗剂的组合物及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105919963A (zh) 2016-05-27 2016-09-07 扬子江药业集团广州海瑞药业有限公司 一种琥珀酸索利那新组合物
JP2017210422A (ja) 2016-05-24 2017-11-30 ニプロ株式会社 医薬組成物、医薬組成物の製造方法、及び非晶質体の安定性を向上させる方法
JP2018039780A (ja) 2016-09-02 2018-03-15 大原薬品工業株式会社 非晶質体ソリフェナシン及び抗酸化剤を含有する固形製剤
JP2018058786A (ja) 2016-10-04 2018-04-12 ニプロ株式会社 医薬組成物、医薬組成物の製造方法、及び非晶質体の安定性を向上させる方法
WO2018145159A1 (en) 2017-02-08 2018-08-16 Rising Phoenix Industries Pty Ltd Terminalia ferdinandiana leaf extract and products containing extract of terminalia ferdinandiana leaf

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008128028A2 (en) * 2007-04-11 2008-10-23 Dr. Reddy's Laboratories Ltd. Solifenacin compositions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017210422A (ja) 2016-05-24 2017-11-30 ニプロ株式会社 医薬組成物、医薬組成物の製造方法、及び非晶質体の安定性を向上させる方法
CN105919963A (zh) 2016-05-27 2016-09-07 扬子江药业集团广州海瑞药业有限公司 一种琥珀酸索利那新组合物
JP2018039780A (ja) 2016-09-02 2018-03-15 大原薬品工業株式会社 非晶質体ソリフェナシン及び抗酸化剤を含有する固形製剤
JP2018058786A (ja) 2016-10-04 2018-04-12 ニプロ株式会社 医薬組成物、医薬組成物の製造方法、及び非晶質体の安定性を向上させる方法
WO2018145159A1 (en) 2017-02-08 2018-08-16 Rising Phoenix Industries Pty Ltd Terminalia ferdinandiana leaf extract and products containing extract of terminalia ferdinandiana leaf

Also Published As

Publication number Publication date
JP2020045323A (ja) 2020-03-26

Similar Documents

Publication Publication Date Title
JP4947820B2 (ja) ナテグリニド含有製剤
HUE026957T2 (en) A pharmaceutical composition comprising a quinoline derivative
JP2018035202A (ja) イルベサルタンとアムロジピンまたはその塩を含有する医薬組成物
JP2024033011A (ja) 医薬組成物
EP2591774B1 (en) Orally disintegrating tablet
JP2012149056A (ja) 新規な安定化固形製剤
JP2019526591A (ja) ロスバスタチン及びエゼチミブを含む医薬組成物並びにその調製方法
JP7198021B2 (ja) コハク酸ソリフェナシン含有製剤
JP6662614B2 (ja) 湿製錠剤、及び湿製錠剤の製造方法
JP2011162531A (ja) フェキソフェナジン含有フイルムコーテイング経口製剤
KR102206104B1 (ko) 실로도신을 포함하는 과립물, 및 이를 포함하는 약학적 조성물 및 제형
JP6816972B2 (ja) エゼチミブ含有医薬組成物及びその製造方法、エゼチミブ含有医薬組成物の硬度低下抑制剤及び硬度低下抑制方法、並びにエゼチミブ含有医薬組成物の吸湿抑制剤及び吸湿抑制方法
JP2015054851A (ja) 被覆経口固形製剤
JPWO2013172297A1 (ja) ６，７−不飽和−７−カルバモイルモルヒナン誘導体含有製剤
JP2016155777A (ja) モンテルカスト又はその塩を含む組成物
WO2020111089A1 (ja) 医薬組成物
JP2022186929A (ja) ダサチニブ無水物含有製剤
JP5065519B1 (ja) 結晶性アトルバスタチンカルシウム含有錠剤の製造方法
JP6077459B2 (ja) 固形製剤
JPWO2004078173A1 (ja) 溶出性の改善された錠剤
JP2020075874A (ja) ルビプロストン含有フィルム状医薬組成物
JP2018184375A (ja) ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
JPWO2007046411A1 (ja) イソキサゾール化合物の安定化方法
US20190070167A1 (en) Pitavastatin containing preparation and method for producing same
US20190290631A1 (en) Pharmaceutical composition comprising rapamycin or derivative thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210716

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210716

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220520

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220722

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221019

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221129

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221216

R150 Certificate of patent or registration of utility model

Ref document number: 7198021

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250